Idera Pharmaceuticals Inc (NASDAQ:IDRA)

2.14
Delayed Data
As of Aug 03
 +0.14 / +7.04%
Today’s Change
0.81
Today|||52-Week Range
3.58
+17.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$67.1M

Company Description

Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.

Contact Information

Idera Pharmaceuticals, Inc.
505 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 348-1600
Investor Relations:

Employees

Shareholders

Mutual fund holders4.26%
Individual stakeholders33.41%
Other institutional21.59%

Top Executives

Vin MilanoPresident, Chief Executive Officer & Director
John J. KirbyChief Financial Officer & Senior Vice President
Elizabeth A. TarkaChief Medical Officer & Senior Vice President
Bryant LimSecretary, Senior VP & General Counsel
Robert Clayton FletcherSVP-Business Development & Strategic Planning